Fortunately, two in vitro studies have demonstrated that oroxylin A has high selectivity between normal cells and cancer cells, which may be attributed to the unfolded protein response (UPR) and AKT pathways (Mu et al., 2009; Xu et al., 2012). This evidence concerns the gene AKT1 and cancer.